Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
MI-2 (Menin-MLL Inhibitor)
CAS:
1271738-62-5
MF:
C18H25N5S2
Structure:
Chemical Name:
CAY10603
CAS:
1045792-66-2
MF:
C22H30N4O6
Structure:
Chemical Name:
MK-2048
CAS:
869901-69-9
MF:
C21H21ClFN5O4
Structure:
Chemical Name:
XL888
CAS:
1149705-71-4
MF:
C29H37N5O3
Structure:
Chemical Name:
NU 6027
CAS:
220036-08-8
MF:
C11H17N5O2
Structure:
Chemical Name:
SGC0946
CAS:
1561178-17-3
MF:
C28H40BrN7O4
Structure:
Chemical Name:
AZ20
CAS:
1233339-22-4
MF:
C21H24N4O3S
Structure:
Chemical Name:
GDC-0152
CAS:
873652-48-3
MF:
C25H34N6O3S
Structure:
Chemical Name:
RG-7388
CAS:
1229705-06-9
MF:
C31H29Cl2F2N3O4
Structure:
Chemical Name:
XL-388
CAS:
1251156-08-7
MF:
C23H22FN3O4S
Structure:
Chemical Name:
AZD-2858
CAS:
486424-20-8
MF:
C21H23N7O3S
Structure:
Chemical Name:
P276
CAS:
920113-03-7
MF:
C21H21Cl2NO5
Structure:
Chemical Name:
MM-102
CAS:
1417329-24-8
MF:
C35H49F2N7O4
Structure:
Chemical Name:
4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline
CAS:
1206711-16-1
MF:
C24H20N4O
Structure:
Chemical Name:
Tubacin
CAS:
537049-40-4
MF:
C41H43N3O7S
Structure:
Chemical Name:
2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
CAS:
1234480-50-2
MF:
C26H30N6O3
Structure:
Chemical Name:
Losmapimod (GW856553X)
CAS:
585543-15-3
MF:
C22H26FN3O2
Structure:
Chemical Name:
4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone
CAS:
890090-75-2
MF:
C30H30Cl2N4O4
Structure:
Chemical Name:
ITF2357
CAS:
732302-99-7
MF:
C24H30ClN3O5
Structure:
Chemical Name:
TAK-700
CAS:
426219-18-3
MF:
C18H17N3O2
Structure:
Chemical Name:
WYE-687
CAS:
1062161-90-3
MF:
C28H32N8O3
Structure:
Chemical Name:
ARRY-334543
CAS:
845272-21-1
MF:
C22H19ClN6O2S
Structure:
Chemical Name:
Nodinitib-1
CAS:
799264-47-4
MF:
C14H13N3O2S
Structure:
Chemical Name:
IKK Inhibitor III, BMS-345541
CAS:
445430-58-0
MF:
C14H17N5
Structure:
Chemical Name:
CYP3cide
CAS:
1390637-82-7
MF:
C26H32N8
Structure:
Chemical Name:
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-
CAS:
120964-45-6
MF:
C12H15ClN4O3
Structure:
Chemical Name:
CEP-32496 (free base)
CAS:
1188910-76-0
MF:
C24H22F3N5O5
Structure:
Chemical Name:
KU 0060648
CAS:
881375-00-4
MF:
C33H34N4O4S
Structure:
Chemical Name:
MS436
CAS:
1395084-25-9
MF:
C18H17N5O3S
Structure:
Chemical Name:
K 02288
CAS:
1431985-92-0
MF:
C20H20N2O4
Structure:
Chemical Name:
ML-323
CAS:
1572414-83-5
MF:
C23H24N6
Structure:
Chemical Name:
LDN212854
CAS:
1432597-26-6
MF:
C25H22N6
Structure:
Chemical Name:
SU 9516
CAS:
377090-84-1
MF:
C13H11N3O2
Structure:
Chemical Name:
Mildronate dihydrate
CAS:
86426-17-7
MF:
C6H14N2O2.2H2O
Structure:
Chemical Name:
Mk-2461 .
CAS:
917879-39-1
MF:
C24H25N5O5S
Structure:
Chemical Name:
1-Methyl-N-[2-methyl-4-[2-(2-methylphenyl)diazenyl]phenyl-1H-pyrazole-5-carboxamide
CAS:
301326-22-7
MF:
C19H19N5O
Structure:
Chemical Name:
Droxinostat
CAS:
99873-43-5
MF:
C11H14ClNO3
Structure:
Chemical Name:
Bikinin
CAS:
188011-69-0
MF:
C9H9BrN2O3
Structure:
Chemical Name:
CP 91149
CAS:
186392-40-5
MF:
C21H21ClN3O3
Structure:
Chemical Name:
NVP-HSP990(HSP990)
CAS:
934343-74-5
MF:
C20H18FN5O2
Structure:
Chemical Name:
AT-13148
CAS:
1056901-62-2
MF:
C17H16ClN3O
Structure:
Chemical Name:
SR 1078
CAS:
1246525-60-9
MF:
C17H10F9NO2
Structure:
Chemical Name:
AST-1306
CAS:
1050500-29-2
MF:
C31H26ClFN4O5S
Structure:
Chemical Name:
AT-101
CAS:
866541-93-7
MF:
C32H34O10
Structure:
Chemical Name:
Poziotinib (HM781-36B)
CAS:
1092364-38-9
MF:
C23H21Cl2FN4O3
Structure:
Chemical Name:
BAY 87-2243
CAS:
1227158-85-1
MF:
C26H26F3N7O2
Structure:
Chemical Name:
IM-12
CAS:
1129669-05-1
MF:
C22H20FN3O2
Structure:
Chemical Name:
SP2509
CAS:
1423715-09-6
MF:
C19H20ClN3O5S
Structure:
Chemical Name:
Mycophenolate mofetil
CAS:
115007-34-6
MF:
C23H31NO7
Structure:
Chemical Name:
GW 842166X
CAS:
666260-75-9
MF:
C18H17Cl2F3N4O2
Structure:
Chemical Name:
PF-2545920
CAS:
1292799-56-4
MF:
C25H20N4O
Structure:
Chemical Name:
NSC 23766 (hydrochloride)
CAS:
1177865-17-6
MF:
C24H35N7
Structure:
Chemical Name:
VER-50589
CAS:
747413-08-7
MF:
C19H17ClN2O5
Structure:
Chemical Name:
(R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide
CAS:
913358-93-7
MF:
C29H31F3N2O3
Structure:
Chemical Name:
6-pentadecylsalicylic acid
CAS:
16611-84-0
MF:
C22H36O3
Structure:
Chemical Name:
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone
CAS:
571203-78-6
MF:
C30H31ClN4O4
Structure:
Chemical Name:
CGS 21680A
CAS:
124431-80-7
MF:
C23H30ClN7O6
Structure:
Chemical Name:
Tie2 kinase inhibitor
CAS:
948557-43-5
MF:
C26H21N3O2S
Structure:
Chemical Name:
LDN-193189 HCl
CAS:
1062368-62-0
MF:
C25H23ClN6
Structure:
Chemical Name:
IPA-3
CAS:
42521-82-4
MF:
C20H14O2S2
Structure:
Chemical Name:
BMS-794833
CAS:
1174046-72-0
MF:
C23H15ClF2N4O3
Structure:
Chemical Name:
KX2-391
CAS:
897016-82-9
MF:
C26H29N3O3
Structure:
Chemical Name:
Vinflunine Tartrate
CAS:
1201898-17-0
MF:
C49H60F2N4O14
Structure:
Chemical Name:
DBeQ
CAS:
177355-84-9
MF:
C22H20N4
Structure:
Chemical Name:
AKT Kinase Inhibitor
CAS:
842148-40-7
MF:
C16H19N7O3
Structure:
Chemical Name:
L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)
CAS:
685898-44-6
MF:
C13H19Cl3N2O3
Structure:
Chemical Name:
GW791343 HCl
CAS:
309712-55-8
MF:
C20H27Cl3F2N4O
Structure:
Chemical Name:
TAK875
CAS:
1374598-80-7
MF:
C58H66O15S2
Structure:
Chemical Name:
RGFP 109
CAS:
1215493-56-3
MF:
C20H25N3O2
Structure:
Chemical Name:
CNX-774
CAS:
1202759-32-7
MF:
C26H22FN7O3
Structure:
Chemical Name:
GNE 7915
CAS:
1351761-44-8
MF:
C19H21F4N5O3
Structure:
Chemical Name:
P 22077
CAS:
1247819-59-5
MF:
C12H7F2NO3S2
Structure:
Chemical Name:
AZD 9668
CAS:
848141-11-7
MF:
C25H22F3N5O4S
Structure:
Chemical Name:
Cabotegravir (GSK744, GSK1265744)
CAS:
1051375-10-0
MF:
C19H17F2N3O5
Structure:
Chemical Name:
5-Carboxy-8-hydroxyquinoline
CAS:
5852-78-8
MF:
C10H7NO3
Structure:
Chemical Name:
Verdinexor (KPT-335)
CAS:
1392136-43-4
MF:
C18H12F6N6O
Structure:
Chemical Name:
PI-3065
CAS:
955977-50-1
MF:
C27H31FN6OS
Structure:
Chemical Name:
Lorlatinib (PF-06463922)
CAS:
1454846-35-5
MF:
C21H19FN6O2
Structure:
Chemical Name:
BRD4770
CAS:
1374601-40-7
MF:
C25H23N3O3
Structure:
Chemical Name:
LDC1267
CAS:
1361030-48-9
MF:
C30H26F2N4O5
Structure:
Chemical Name:
N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA
CAS:
792173-99-0
MF:
C17H13N5O2
Structure:
Chemical Name:
EHT1864
CAS:
754240-09-0
MF:
C25H27F3N2O4S2HCl
Structure:
Chemical Name:
6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
CAS:
1139889-93-2
MF:
C17H14F2N2
Structure:
Chemical Name:
LRRK2-IN-1
CAS:
1234480-84-2
MF:
C31H38N8O3
Structure:
Chemical Name:
VER-49009
CAS:
940289-57-6
MF:
C19H18ClN3O4
Structure:
Chemical Name:
6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one
CAS:
1286739-19-2
MF:
C29H28ClN7OS
Structure:
Chemical Name:
Teneligliptin Hydrobromide
CAS:
906093-29-6
MF:
C22H31BrN6OS
Structure:
Chemical Name:
OG-L002
CAS:
1357302-64-7
MF:
C15H15NO
Structure:
Chemical Name:
KPT-330
CAS:
1393477-72-9
MF:
C17H11F6N7O
Structure:
Chemical Name:
WAY100635
CAS:
1092679-51-0
MF:
C29H38N4O6
Structure:
Chemical Name:
LDC000067
CAS:
1073485-20-7
MF:
C18H18N4O3S
Structure:
Chemical Name:
WS3
CAS:
1421227-52-2
MF:
C28H30F3N7O3
Structure:
Chemical Name:
Raf265 derivative
CAS:
1942849-27-5
MF:
C23H14F6N6O
Structure:
Chemical Name:
LMK-235
CAS:
1418033-25-6
MF:
C15H22N2O4
Structure:
Chemical Name:
GSK-2110183C
CAS:
1047644-62-1
MF:
C18H17Cl2FN4OS
Structure:
Chemical Name:
BS-181 HCl
CAS:
1397219-81-6
MF:
C22H33ClN6
Structure:
Chemical Name:
RGFP966
CAS:
1396841-57-8
MF:
C21H19FN4O
Structure:
Chemical Name:
ReModelin hydrobroMide
CAS:
1622921-15-6
MF:
C15H15BrN4S
Structure:
Chemical Name:
WIKI4
CAS:
838818-26-1
MF:
C29H23N5O3S
Structure:
Chemical Name:
FTI 277 HYDROCHLORIDE
CAS:
180977-34-8
MF:
C22H30ClN3O3S2